These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1214 related items for PubMed ID: 28104301

  • 1. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M, Mirocha J, Reinsmoen NL, Vo AA, Choi J, Kahwaji JM, Peng A, Villicana R, Jordan SC.
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [Abstract] [Full Text] [Related]

  • 2. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž, Kainz A, Kozakowski N, Oberbauer R, Regele H, Bond G, Böhmig GA.
    Clin J Am Soc Nephrol; 2015 Aug 07; 10(8):1435-43. PubMed ID: 26071493
    [Abstract] [Full Text] [Related]

  • 3. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
    Vo AA, Sinha A, Haas M, Choi J, Mirocha J, Kahwaji J, Peng A, Villicana R, Jordan SC.
    Transplantation; 2015 Jul 07; 99(7):1423-30. PubMed ID: 25606792
    [Abstract] [Full Text] [Related]

  • 4. Expression patterns of B cells in acute kidney transplant rejection.
    Carpio VN, Noronha Ide L, Martins HL, Jobim LF, Gil BC, Külzer AS, Loreto Mda S, Gonçalves LF, Manfro RC, Veronese FV.
    Exp Clin Transplant; 2014 Oct 07; 12(5):405-14. PubMed ID: 25299368
    [Abstract] [Full Text] [Related]

  • 5. Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.
    Bailly E, Anglicheau D, Blancho G, Gatault P, Vuiblet V, Chatelet V, Morelon E, Malvezzi P, Parissiadis A, Tourret J, Guidicelli G, Sayegh J, Mousson C, Grimbert P, Top I, Le Quintrec M, Purgus R, Westeel PF, Proust B, Chabot V, Lebranchu Y, Dehaut F, Büchler M.
    Transplantation; 2018 Apr 07; 102(4):688-698. PubMed ID: 29135832
    [Abstract] [Full Text] [Related]

  • 6. Rejection of the Renal Allograft in the Absence of Demonstrable Antibody and Complement.
    Zhao X, Huang G, Randhawa S, Zeng G, Lunz J, Randhawa P.
    Transplantation; 2017 Feb 07; 101(2):395-401. PubMed ID: 26901079
    [Abstract] [Full Text] [Related]

  • 7. Banff 2013 update: Pearls and pitfalls in transplant renal pathology.
    Hara S.
    Nephrology (Carlton); 2015 Jul 07; 20 Suppl 2():2-8. PubMed ID: 26031578
    [Abstract] [Full Text] [Related]

  • 8. Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.
    Niikura T, Yamamoto I, Nakada Y, Kamejima S, Katsumata H, Yamakawa T, Furuya M, Mafune A, Kobayashi A, Tanno Y, Miki J, Yamada H, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2015 Jul 07; 20 Suppl 2():75-8. PubMed ID: 26031592
    [Abstract] [Full Text] [Related]

  • 9. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
    Sis B, Halloran PF.
    Curr Opin Organ Transplant; 2010 Feb 07; 15(1):42-8. PubMed ID: 20009933
    [Abstract] [Full Text] [Related]

  • 10. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
    Shimizu T, Tanabe T, Omoto K, Ishida H, Tanabe K.
    Transplant Proc; 2012 Jan 07; 44(1):230-5. PubMed ID: 22310621
    [Abstract] [Full Text] [Related]

  • 11. Late Antibody-Mediated Rejection in a Large Prospective Cross-Sectional Study of Kidney Allograft Recipients--Preliminary Results of the Screening Phase of the BORTEJECT Trial.
    Eskandary F, Bond G, Regele H, Kozakowski N, Kikić Z, Wahrmann M, Haslacher H, Oberbauer R, Ramassar V, Halloran P, Böhmig GA.
    Clin Transpl; 2014 Jan 07; ():189-95. PubMed ID: 26281144
    [Abstract] [Full Text] [Related]

  • 12. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.
    Transplantation; 2013 Jan 27; 95(2):341-6. PubMed ID: 23197178
    [Abstract] [Full Text] [Related]

  • 13. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, Lefaucheur C.
    Kidney Int; 2017 Sep 27; 92(3):729-742. PubMed ID: 28554738
    [Abstract] [Full Text] [Related]

  • 14. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection.
    Tsuji T, Yanai M, Itami H, Ishii Y, Akimoto M, Fukuzawa N, Harada H, Fukasawa Y.
    Nephrology (Carlton); 2015 Jul 27; 20 Suppl 2():26-30. PubMed ID: 26031582
    [Abstract] [Full Text] [Related]

  • 15. Beyond Criteria and Definitions: Outcome of a Standardized Antibody-Mediated Rejection Protocol with a Diagnostic Schema Different from the Banff 2009 Criteria.
    Rendulic T, Ramon DS, Killen PD, Samaniego-Picota M, Park JM.
    Clin Transpl; 2014 Jul 27; ():179-87. PubMed ID: 26281143
    [Abstract] [Full Text] [Related]

  • 16. Antibody-mediated rejection due to anti-HLA-DQ antibody after pregnancy and delivery in a female kidney transplant recipient.
    Sagasaki M, Nakada Y, Yamamoto I, Kawabe M, Yamakawa T, Katsumata H, Mafune A, Katsuma A, Kobayashi A, Koike K, Koike Y, Miki J, Yamada H, Kimura T, Tanno Y, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2018 Jul 27; 23 Suppl 2():81-84. PubMed ID: 29968405
    [Abstract] [Full Text] [Related]

  • 17. Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients.
    Djamali A, Muth BL, Ellis TM, Mohamed M, Fernandez LA, Miller KM, Bellingham JM, Odorico JS, Mezrich JD, Pirsch JD, D'Alessandro TM, Vidyasagar V, Hofmann RM, Torrealba JR, Kaufman DB, Foley DP.
    Kidney Int; 2013 Jun 27; 83(6):1185-92. PubMed ID: 23447068
    [Abstract] [Full Text] [Related]

  • 18. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
    Senev A, Coemans M, Lerut E, Van Sandt V, Daniëls L, Kuypers D, Sprangers B, Emonds MP, Naesens M.
    Am J Transplant; 2019 Mar 27; 19(3):763-780. PubMed ID: 30107078
    [Abstract] [Full Text] [Related]

  • 19. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
    OʼLeary JG, Demetris AJ, Philippe A, Freeman R, Cai J, Heidecke H, Smith C, Hart B, Jennings LW, Catar R, Everly M, Klintmalm GB, Dragun D.
    Transplantation; 2017 Oct 27; 101(10):2399-2409. PubMed ID: 28665894
    [Abstract] [Full Text] [Related]

  • 20. Antibody-mediated rejection and treatment in pediatric patients: one center's experience.
    Gulleroglu K, Baskin E, Bayrakci US, Turan M, Ozdemir BH, Moray G, Karakayali H, Haberal M.
    Exp Clin Transplant; 2013 Oct 27; 11(5):404-7. PubMed ID: 24128133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.